Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference49 articles.
1. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukemia;Ruibao;Nat Rev Cancer,2005
2. The diversity of Bcr-Abl fusion proteins and their relationship to leukemia phenotype;Melo;Blood,1996
3. Chronic myeloid leukemia—advances in biology and new approaches to treatment;Goldman;N Engl J Med,2003
4. The BCR-ABL story: bench to bedside and back;Wong;Annu Rev Immunol,2004
5. BCR/ABL and IL-3 activate Rap1 to stimulate the B-Raf/MEK/Erk and Akt signaling pathways and to regulate proliferation, apoptosis, and adhesion;Jin;Oncogene,2006
Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. High expression of COX-2 and MDR1 implicate resistance development to imatinib therapy in chronic myeloid leukemia patients;2023-12-28
2. Shc3 facilitates breast cancer drug resistance by interacting with ErbB2 to initiate ErbB2/COX2/MDR1 axis;Cancer Medicine;2023-03-07
3. Perspectives of the Application of Non-Steroidal Anti-Inflammatory Drugs in Cancer Therapy: Attempts to Overcome Their Unfavorable Side Effects;Cancers;2023-01-12
4. Nanoenabled Tumor Energy Metabolism Disorder via Sonodynamic Therapy for Multidrug Resistance Reversal and Metastasis Inhibition;ACS Applied Materials & Interfaces;2022-12-28
5. EVI1 upregulates PTGS1 (COX1) and decreases the action of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia cells;International Journal of Hematology;2022-10-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3